Top

Abdominal Radiology

Published in:

01-07-2020 | Prostate Cancer | Special Section: Male Pelvis

Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies

Authors: Aileen O’Shea, Aoife Kilcoyne, Sandeep S. Hedgire, Mukesh G. Harisinghani

Published in: Abdominal Radiology | Issue 7/2020

Abstract

Purpose

Accurate nodal staging for male urogenital malignancies has important implications for therapy and prognosis. Male pelvic malignancies, including prostatic, penile, testicular, and bladder cancer, typically metastasize to regional lymph nodes first which is reported by the N-stage. Spread beyond these groups to non-regional nodes is regarded as M-stage disease.

Methods

In this review, we discuss the typical patterns of male pelvic lymphatic drainage and the tumor-specific regional nodal chains.

Results

The impact of tumor-specific imaging features and the implications of previous treatments on staging are discussed.

Conclusions

While anatomic imaging, including CT and MRI, is the most widely employed imaging modality at present, newer functional imaging techniques have demonstrated promise in the accurate identification and characterization of nodal metastases.

Richter S, Ruether JD, Wood L, et al. Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Can Urol Assoc J. 2013;7(11-12):E797-811. https://doi.org/10.5489/cuaj.1794 CrossRefPubMedPubMedCentral

Hale GR, Teplitsky S, Truong H, Gold SA, Bloom JB, Agarwal PK. Lymph node imaging in testicular cancer. Transl Androl Urol. 2018;7(5):864. https://doi.org/10.21037/tau.2018.07.18 CrossRefPubMedPubMedCentral

Muteganya R, Goldman S, Aoun F, Roumeguère T, Albisinni S. Current Imaging Techniques for Lymph Node Staging in Prostate Cancer: A Review. Front Surg. 2018;5:74. https://doi.org/10.3389/fsurg.2018.00074 CrossRefPubMedPubMedCentral

Mao Y, Hedgire S, Harisinghani M. Radiologic Assessment of Lymph Nodes in Oncologic Patients. Curr Radiol Rep. 2014;2(2):36. https://doi.org/10.1007/s40134-013-0036-6 CrossRef

Park JM, Charnsangavej C, Yoshimitsu K, Herron DH, Robinson TJ, Wallace S. Pathways of nodal metastasis from pelvic tumors: CT demonstration. RadioGraphics. 1994;14(6):1309-1321. https://doi.org/10.1148/radiographics.14.6.7855343 CrossRefPubMed

Paño B, Sebastià C, Buñesch L, et al. Pathways of Lymphatic Spread in Male Urogenital Pelvic Malignancies. RadioGraphics. 2011;31(1):135-160. https://doi.org/10.1148/rg.311105072 CrossRefPubMed

Hedgire SS, Pargaonkar VK, Elmi A, Harisinghani AM, Harisinghani MG. Pelvic Nodal Imaging. Radiol Clin North Am. 2012;50(6):1111-1125. https://doi.org/10.1016/j.rcl.2012.08.002 CrossRefPubMed

Saokar A, Islam T, Jantsch M, Saksena MA, Hahn PF, Harisinghani MG. Detection of lymph nodes in pelvic malignancies with computed tomography and magnetic resonance imaging. Clin Imaging. 2010;34(5):361-366. https://doi.org/10.1016/j.clinimag.2009.07.004 CrossRefPubMed

Ganeshalingam S, Koh D-M. Nodal staging. Cancer Imaging. 2009;9(1):104-111. https://doi.org/10.1102/1470-7330.2009.0017 CrossRefPubMedPubMedCentral

10.

Einstein DM, Singer AA, Chilcote WA, Desai RK. Abdominal lymphadenopathy: spectrum of CT findings. Radiographics. 1991;11(3):457-472. https://doi.org/10.1148/radiographics.11.3.1852937 CrossRefPubMed

11.

Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology. 1995;194(2):349-355. https://doi.org/10.1148/radiology.194.2.7824709 CrossRefPubMed

12.

Tiguert R, Gheiler EL, Tefilli M V, et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology. 1999;53(2):367-371. http://www.ncbi.nlm.nih.gov/pubmed/9933056. Accessed June 2, 2019.

13.

McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic Metastases from Pelvic Tumors: Anatomic Classification, Characterization, and Staging. Radiology. 2010;254(1):31-46. https://doi.org/10.1148/radiol.2541090361 CrossRefPubMed

14.

Lam TBL. Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging. Cancer Commun (London, England). 2018;38(1):2. https://doi.org/10.1186/s40880-018-0271-6 CrossRefPubMedCentral

15.

Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology. 1995;197(3):705-711. https://doi.org/10.1148/radiology.197.3.7480743 CrossRefPubMed

16.

Brown G, Richards C, Bourne M et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003. https://doi.org/10.1148/radiol.2272011747 CrossRefPubMed

17.

Husband JE, Koh D-M. Multimodality imaging of testicular tumours: Tuesday 12 October 2004, 08:30–09:00. Cancer Imaging. 2004;4(Spec No B):S101. https://doi.org/10.1102/1470-7330.2004.0052

18.

Coursey Moreno C, Small WC, Camacho JC, et al. Testicular Tumors: What Radiologists Need to Know—Differential Diagnosis, Staging, and Management. RadioGraphics. 2015;35(2):400-415. https://doi.org/10.1148/rg.352140097 CrossRefPubMed

19.

Furlow B. PET-CT Cancer Imaging. Radiol Technol. 2018;90(2):149CT-170CT. http://www.ncbi.nlm.nih.gov/pubmed/30420583. Accessed June 6, 2019.

20.

Rohren EM, Turkington TG, Coleman RE. Clinical Applications of PET in Oncology. Radiology. 2004;231(2):305-332. https://doi.org/10.1148/radiol.2312021185 CrossRefPubMed

21.

Sotoudeh H, Sharma A, Fowler KJ, McConathy J, Dehdashti F. Clinical application of PET/MRI in oncology. J Magn Reson Imaging. 2016;44(2):265-276. https://doi.org/10.1002/jmri.25161 CrossRefPubMed

22.

Wong TZ, Paulson EK, Nelson RC, Patz EF, Coleman RE. Practical Approach to Diagnostic CT Combined with PET. Am J Roentgenol. 2007;188(3):622-629. https://doi.org/10.2214/ajr.06.0813 CrossRef

23.

Antoch G, Saoudi N, Kuehl H, et al. Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy- d -Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET. J Clin Oncol. 2004;22(21):4357-4368. https://doi.org/10.1200/jco.2004.08.120 CrossRefPubMed

24.

Graafland NM, Leijte JAP, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S. Scanning with 18F-FDG-PET/CT for Detection of Pelvic Nodal Involvement in Inguinal Node-Positive Penile Carcinoma. Eur Urol. 2009;56(2):339-345. https://doi.org/10.1016/j.eururo.2009.05.016 CrossRefPubMed

25.

Zhu Y, Zhang SL, Ye DW, Yao XD, Jiang ZX, Zhou XY. Predicting Pelvic Lymph Node Metastases in Penile Cancer Patients: A Comparison of Computed Tomography, Cloquet’s Node, and Disease Burden of Inguinal Lymph Nodes. Onkologie. 2008;31(1-2):37-41. https://doi.org/10.1159/000112462 CrossRefPubMed

26.

Scher B, Seitz M, Reiser M, et al. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med. 2005;46(9):1460-1465. http://www.ncbi.nlm.nih.gov/pubmed/16157528. Accessed June 6, 2019.

27.

Sadeghi R, Gholami H, Zakavi SR, Kakhki VRD, Horenblas S. Accuracy of 18F-FDG PET/CT for Diagnosing Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma. Clin Nucl Med. 2012;37(5):436-441. https://doi.org/10.1097/rlu.0b013e318238f6ea CrossRefPubMed

28.

Ottenhof S, Djajadiningrat R, Graafland N, Versleijen M, Vegt E, Horenblas S. Use of FDG-PET/CT for staging pelvic lymph nodes in 100 patients with penile carcinoma. Eur Urol Suppl. 2018;17(2):e46. https://doi.org/10.1016/s1569-9056(18)30884-4 CrossRef

29.

Yacoub JH, Oto A, Allen BC, et al. ACR Appropriateness Criteria ® 2 Staging Testicular Malignancy Expert Panel on Urologic Imaging: Summary of Literature Review

30.

Müller J, Schrader AJ, Jentzmik F, Schrader M. Beurteilung von Residualtumoren nach Systemtherapie des metastasierten Seminoms. Urologe. 2011;50(3):322-327. https://doi.org/10.1007/s00120-010-2469-3 CrossRefPubMed

31.

Treglia G, Sadeghi R, Annunziata S, Caldarella C, Bertagna F, Giovanella L. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: Systematic review and meta-analysis. Biomed Res Int. 2014. https://doi.org/10.1155/2014/852681 CrossRefPubMedPubMedCentral

32.

Oechsle K, Hartmann M, Brenner W, et al. [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy: The German Multicenter Positron Emission Tomography Study Group. J Clin Oncol. 2008;26(36):5930-5935. https://doi.org/10.1200/jco.2008.17.1157 CrossRefPubMed

33.

Cook GJ, Sohaib A, Huddart RA, Dearnaley DP, Horwich A, Chua S. The role of 18F-FDG PET/CT in the management of testicular cancers. Nucl Med Commun. 2015;36(7):702-708. https://doi.org/10.1097/mnm.0000000000000303 CrossRefPubMed

34.

de Wit M, Brenner W, Hartmann M, et al. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial. Ann Oncol. 2008;19(9):1619-1623. https://doi.org/10.1093/annonc/mdn170 CrossRefPubMed

35.

Becherer A. PET in Testicular Cancer. In: Methods in Molecular Biology (Clifton, N.J.). Vol 727.; 2011:225-241. https://doi.org/10.1007/978-1-61779-062-1_13

36.

Van Der Pol CB, Sahni ; V Anik, Eberhardt SC, et al. ACR Appropriateness Criteria ® 2 Pretreatment Staging of Muscle-Invasive Bladder Cancer Expert Panel on Urologic Imaging

37.

Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim C-S. FDG PET–CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy. Ann Surg Oncol. 2015;22(9):3150-3156. https://doi.org/10.1245/s10434-015-4369-7 CrossRefPubMed

38.

Hövels AM, Heesakkers RAM, Adang EM, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387-395. https://doi.org/10.1016/j.crad.2007.05.022 CrossRefPubMed

39.

ROEHL KA, HAN M, RAMOS CG, ANTENOR JA V., CATALONA WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172(3):910-914. https://doi.org/10.1097/01.ju.0000134888.22332.bb

40.

Lee RJ, Armstrong AJ, Victor AD, et al. NCCN Guidelines Panel Disclosures NCCN Guidelines Version 1.2018 Prostate Cancer Continue.; 2018.

41.

Evans JD, Jethwa KR, Ost P, et al. Basic Original Report Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease. 2018. https://doi.org/10.1016/j.prro.2017.07.012 CrossRef

42.

Fanti S, Minozzi S, Castellucci P, et al. PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data. Eur J Nucl Med Mol Imaging. 2016;43(1):55-69. https://doi.org/10.1007/s00259-015-3202-7 CrossRefPubMed

43.

Selnæs KM, Krüger-Stokke B, Elschot M, et al. 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients. Eur Radiol. 2018;28(8):3151-3159. https://doi.org/10.1007/s00330-017-5213-1 CrossRefPubMed

44.

Wallitt KL, Khan SR, Dubash S, Tam HH, Khan S, Barwick TD. Clinical PET Imaging in Prostate Cancer. RadioGraphics. 2017;37(5):1512-1536. https://doi.org/10.1148/rg.2017170035 CrossRefPubMed

45.

Sumi M, Van Cauteren M, Nakamura T. MR Microimaging of Benign and Malignant Nodes in the Neck. Am J Roentgenol. 2006;186(3):749-757. https://doi.org/10.2214/ajr.04.1832 CrossRef

46.

Abdel Razek AAK, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16(7):1468-1477. https://doi.org/10.1007/s00330-005-0133-x CrossRefPubMed

47.

Roy C, Bierry G, Matau A, Bazille G, Pasquali R. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol. 2010;20(8):1803-1811. https://doi.org/10.1007/s00330-010-1736-4 CrossRefPubMed

48.

Mir N, Sohaib S, Collins D, Koh D. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol. 2010;54(4):358-364. https://doi.org/10.1111/j.1754-9485.2010.02182.x CrossRefPubMed

49.

Koh D-M, Collins DJ. Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology. Am J Roentgenol. 2007;188(6):1622-1635. https://doi.org/10.2214/ajr.06.1403 CrossRef

50.

Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients. Eur Urol. 2009;55(4):761-769. https://doi.org/10.1016/j.eururo.2008.12.034 CrossRefPubMed

51.

Anzai Y, McLachlan S, Morris M, Saxton R, Lufkin RB. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol. 1994;15(1):87-94. http://www.ncbi.nlm.nih.gov/pubmed/7511324. Accessed June 4, 2019.

52.

Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. N Engl J Med. 2003;348(25):2491-2499. https://doi.org/10.1056/nejmoa022749 CrossRefPubMed

53.

Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex). Acad Radiol. 1998;5:S167-S169. https://doi.org/10.1016/s1076-6332(98)80095-0 CrossRefPubMed

54.

Morisawa N, Koyama T, Togashi K. Metastatic lymph nodes in urogenital cancers: contribution of imaging findings. Abdom Imaging. 2006;31(5):620-629. https://doi.org/10.1007/s00261-005-0244-5 CrossRefPubMed

55.

Weckermann D, Holl G, Dorn R, Wagner T, Harzmann R. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int. 2007;99(5):1036-1040. https://doi.org/10.1111/j.1464-410x.2007.06791.x CrossRefPubMed

56.

Kreydin EI, Barrisford GW, Feldman AS, Preston MA. Testicular Cancer: What the Radiologist Needs to Know. Am J Roentgenol. 2013;200(6):1215-1225. https://doi.org/10.2214/ajr.12.10319 CrossRef

57.

Sohaib SA, Koh D-M, Husband JE. The Role of Imaging in the Diagnosis, Staging, and Management of Testicular Cancer. Am J Roentgenol. 2008;191(2):387-395. https://doi.org/10.2214/ajr.07.2758 CrossRef

58.

Yeh SD, Morse MJ, Grando R, Kleinert EL, Whitmore WF. Lymphoscintigraphic studies of lymphatic drainage from the testes. Clin Nucl Med. 1986;11(12):823-827. http://www.ncbi.nlm.nih.gov/pubmed/3028686. Accessed July 10, 2019.

59.

Ray B, Hajdu SI, Whitmore WF. Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer. 1974;33(2):340-348. https://doi.org/10.1002/1097-0142(197402)33:2%3c340::aid-cncr2820330207%3e3.0.co;2-y CrossRefPubMed

60.

Daugaard G, Karas V, Sommer P. Inguinal metastases from testicular cancer. BJU Int. 2006;97(4):724-726. https://doi.org/10.1111/j.1464-410x.2006.06017.x CrossRefPubMed

61.

Capelouto CC, Clark PE, Ransil BJ, Loughlin KR. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol. 1995;153(3 Pt 2):981-985. http://www.ncbi.nlm.nih.gov/pubmed/7853587. Accessed July 10, 2019.

62.

Bloom JB, Stern M, Patel NH, Zhang M, Phillips JL. Detection of lymph node metastases in penile cancer. Transl Androl Urol. 2018;7(5):879-886. https://doi.org/10.21037/tau.2018.08.01 CrossRefPubMedPubMedCentral

63.

Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B. Sentinel lymph node imaging in urologic oncology. Transl Androl Urol. 2018;7(5):887-902. https://doi.org/10.21037/tau.2018.08.23 CrossRefPubMedPubMedCentral

64.

Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing World. Lancet Oncol. 2004;5(4):240-247. https://doi.org/10.1016/s1470-2045(04)01427-5 CrossRefPubMed

65.

Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Staging of bladder cancer. Histopathology. 2019;74(1):112-134. https://doi.org/10.1111/his.13734 CrossRefPubMed

66.

Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol. 2001;166(1):19-23. http://www.ncbi.nlm.nih.gov/pubmed/11435814. Accessed July 11, 2019.

67.

Liedberg F, Månsson W. Lymph Node Metastasis in Bladder Cancer. Eur Urol. 2006;49(1):13-21. https://doi.org/10.1016/j.eururo.2005.08.007 CrossRefPubMed

68.

Vikram R, Sandler CM, Ng CS. Imaging and Staging of Transitional Cell Carcinoma: Part 1, Lower Urinary Tract. Am J Roentgenol. 2009;192(6):1481-1487. https://doi.org/10.2214/ajr.08.1318 CrossRef

Title: Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies
Authors: Aileen O’Shea
Aoife Kilcoyne
Sandeep S. Hedgire
Mukesh G. Harisinghani
Publication date: 01-07-2020
Publisher: Springer US
Keywords: Prostate Cancer
Metastasis
Prostate Cancer
Penile Cancer
Penile Cancer
Published in: Abdominal Radiology / Issue 7/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-019-02285-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2020

Sonography of the penis/erectile dysfunction

A case of focal confluent hepatic fibrosis in the patient with hepatitis C virus-related liver cirrhosis: a mimic of cholangiolocellular carcinoma

Utility of dynamic MRA in the evaluation of male erectile dysfunction

A case of intrahepatic splenosis: usefulness of splenic scintigraphy

Mucinous cystic neoplasm of the liver communicated with intrahepatic duct exhibiting peculiar chronological change in MR imaging appearances: a case report

Imaging of the adult male urethra, penile prostheses and artificial urinary sphincters

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page